Multiple Myeloma
From the Journals
Genomic abnormalities shed light on racial disparity in myeloma
The researchers relied on genetic ancestry, rather than self-reported race, to evaluate myeloma disparities.
News
Palliative care guidelines relevant for hematologists, doc says
The latest edition of the national palliative care guidelines provides new clinical strategies relevant to hematology practice in the United...
News
Three gene types drive MM disparity in African Americans
Researchers say they may have determined why African Americans have a two- to three-fold increased risk of multiple myeloma (MM) compared to...
News
Better PFS may not mean better HRQOL
Cancer treatments that prolong progression-free survival (PFS) may not improve health-related quality of life (HRQOL), researchers reported in...
News
FDA offers guidance on MRD assessment in blood cancer trials
The draft guidance document provides advice to industry on how to use minimal residual disease as a biomarker in clinical trials of hematologic...
News
FDA issues draft guidance on MRD
The U.S.
News
Questions surround MRD assessment in MM
DUBROVNIK, CROATIA—Clinical trials are needed to answer the many questions related to minimal residual disease (MRD) assessment in multiple...
News
STRO-001 receives orphan designation for MM
The U.S.
News
Selinexor receives priority review for penta-refractory MM
The U.S.
News
Quadruplet therapy could be the future in MM
New York—Four-drug combinations are holding promise for the treatment of multiple myeloma (MM), although data from additional randomized trials...
News
Carfilzomib receives approval for once-weekly dosing
The U.S.